MENU
+Compare
ENLV
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$1.20
Change
-$0.01 (-0.83%)
Capitalization
27.67M

ENLV Enlivex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ENLV with price predictions
Jun 27, 2025

Momentum Indicator for ENLV turns positive, indicating new upward trend

ENLV saw its Momentum Indicator move above the 0 level on June 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned positive. In of the 99 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ENLV just turned positive on June 16, 2025. Looking at past instances where ENLV's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

ENLV moved above its 50-day moving average on June 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ENLV crossed bullishly above the 50-day moving average on June 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENLV advanced for three days, in of 203 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ENLV broke above its upper Bollinger Band on June 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ENLV entered a downward trend on June 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.388) is normal, around the industry mean (16.326). P/E Ratio (0.000) is within average values for comparable stocks, (58.407). ENLV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.768).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ENLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENLV is expected to report earnings to -15 cents per share on August 18

Enlivex Therapeutics Ltd ENLV Stock Earnings Reports
Q2'25
Est.
$-0.15
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.03
The last earnings report on May 23 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 68.22K shares outstanding, the current market capitalization sits at 27.67M.
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARAY1.380.06
+4.55%
Accuray
CTSH77.59N/A
N/A
Cognizant Technology Solutions Corp
FBRT11.03-0.04
-0.36%
Franklin BSP Realty Trust
ADMA18.16-0.24
-1.30%
ADMA Biologics
KLTO0.72-0.53
-42.39%
Klotho Neurosciences Inc

ENLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENLV has been loosely correlated with APVO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ENLV jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENLV
1D Price
Change %
ENLV100%
-4.13%
APVO - ENLV
39%
Loosely correlated
-4.64%
FATE - ENLV
32%
Poorly correlated
-5.45%
VKTX - ENLV
30%
Poorly correlated
-5.82%
SLNO - ENLV
29%
Poorly correlated
-0.92%
AXON - ENLV
29%
Poorly correlated
+1.82%
More